← Leaderboards
Oliver Eickelberg
University Of Pittsburgh At Pittsburgh
$4,701,908
Attributed
$6,075,546
Total exposure
5
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.1M · FY2019–25$2M$1.5M$1M$500K$0
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$6,075,546 · 5
By mechanism
R01$4,006,710 · 2
P50$1,129,238 · 2
R25$939,598 · 1
Top collaborators
- Kathleen C Barnes2 shared
- Marta Bueno Fernandez2 shared
- Sonia Castro Flores2 shared
Most similar at University Of Pittsburgh At Pittsburgh
Same institution · by research overlap
- Rebecca C Thurston$16,560,074
- Sioban D Harlow$25,428,790
- Jane Cauley$32,838,985
- Carol A Feghali-Bostwick$17,984,586
- Robert L Ferris$24,076,317
Others in their field
Other Emerging Leaders on “Lung”
- Sonia M Thomas · Research Triangle Institute$701,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- Chanza Baytop · Westat, Inc.$271,217,917
- Leonard Freedman · Leidos Biomedical Research, Inc.$49,374,001
- Prasant Mohapatra · University Of California At Davis$40,346,250
- Greg Yothers · University Of Chicago$35,003,821
Research focus
LungCellsNovel TherapeuticsAffectInsightAreaPulmonary FibrosisProteomicsMapsFibrosisProteinsCell CommunicationIdiopathic Pulmonary FibrosisAsthmaHistologicMesenchymalMolecularFibroblastsExhibitsExtracellular MatrixLung DiseasesMass Spectrum AnalysisCuesInterstitial Lung Diseases
Grant awards (12)
Role of plasma cells in chronic rejection after lung transplantation$747,239
R01 · FY2025 · HL · contact PI
From proteomics and genomics to therapeutics in systemic sclerosis interstitial lung disease$234,488
P50 · FY2025 · AR · contact PI
Role of plasma cells in chronic rejection after lung transplantation$747,239
R01 · FY2024 · HL · contact PI
From proteomics and genomics to therapeutics in systemic sclerosis interstitial lung disease$298,250
P50 · FY2024 · AR · contact PI
ECM Proteomics in lung fibrosis$621,441
R01 · FY2023 · HL · contact PI
From proteomics and genomics to therapeutics in systemic sclerosis interstitial lung disease$298,250
P50 · FY2023 · AR · contact PI
ECM Proteomics in lung fibrosis$616,663
R01 · FY2022 · HL · contact PI
From proteomics and genomics to therapeutics in systemic sclerosis interstitial lung disease$298,250
P50 · FY2022 · AR · contact PI
ECM Proteomics in lung fibrosis$612,192
R01 · FY2021 · HL · contact PI
Extracellular matrix composition and crosslinking patterns determine resident cell function in lung fibrosis$661,936
R01 · FY2020 · HL · contact PI
PRIDE Academy: Impact of Ancestry and Gender to omics of lung diseases$469,799
R25 · FY2020 · HL
PRIDE Academy: Impact of Ancestry and Gender to omics of lung diseases$469,799
R25 · FY2019 · HL